Brazil Approval for Sanofi's Dengue Vaccine
January 07, 2016.
Brazil has approved Sanofi Pasteur’s new dengue vaccine Dengvaxia as a preventive tool.
Brazil's regulator ANVISA approved the vaccine to prevent all four types of dengue in people ages 9 to 45 in regions where the tropical disease is present. More than 1.4 million Brazilians were infected with the virus this outbreak season,.
Recent Videos
Related Content
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025Article
As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
